title: [Recurrence of encephalitis after 25 years due to anti-NMDA receptor antibodies].
authors.forename: X
authors.initials: X
authors.lastname: Rodriguez-Osorio
authors.forename: G
authors.initials: G
authors.lastname: Fernandez-Pajarin
authors.forename: S
authors.initials: S
authors.lastname: Arias-Rivas
authors.forename: I
authors.initials: I
authors.lastname: Requena-Caballero
authors.forename: F J
authors.initials: FJ
authors.lastname: Lopez-Gonzalez
authors.affiliation: Complejo Hospitalario Universitario de Santiago de Compostela, 15706 Santiago de Compostela, Espana.
authors.forename: M
authors.initials: M
authors.lastname: Arias
mesh_terms: D060426:Anti-N-Methyl-D-Aspartate Receptor Encephalitis / Q000150:complications / Q000188:drug therapy / Q000276:immunology*; D000927:Anticonvulsants / Q000627:therapeutic use; D001323:Autoantibodies / Q000134:cerebrospinal fluid / Q000276:immunology*; D001324:Autoantigens / Q000276:immunology*; D003422:Critical Care; D004359:Drug Therapy, Combination; D005473:Fluoxetine / Q000627:therapeutic use; D006212:Hallucinations / Q000209:etiology; D006801:Humans; D016756:Immunoglobulins, Intravenous / Q000627:therapeutic use; D007806:Language Disorders / Q000209:etiology; D008279:Magnetic Resonance Imaging; D008297:Male; D001523:Mental Disorders / Q000209:etiology; D008775:Methylprednisolone / Q000627:therapeutic use; D008875:Middle Aged; D010291:Paresis / Q000209:etiology; D016194:Receptors, N-Methyl-D-Aspartate / Q000276:immunology*; D012008:Recurrence; D012120:Respiration Disorders / Q000209:etiology; D012640:Seizures / Q000188:drug therapy / Q000209:etiology; D013997:Time Factors
chemical_list: D000927:Anticonvulsants; D001323:Autoantibodies; D001324:Autoantigens; D016756:Immunoglobulins, Intravenous; D016194:Receptors, N-Methyl-D-Aspartate; D005473:Fluoxetine; D008775:Methylprednisolone